{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:41:33Z","timestamp":1763415693547,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>COVID-19 is a pandemic affecting 185 countries, including Indonesia. Cardiovascular diseases (CVD) in COVID-19 patients were linked to worse clinical outcomes. However, the association remained inconclusive due to limited data in Indonesia. This study aimed to determine the association between CVD in COVID-19 pneumonia patients with its clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study was conducted in four Indonesian hospitals, enrolling 584 adult COVID-19 pneumonia patients from September 2020 to July 2021. Patients were categorized into two groups: non-CVD and CVD [hypertension, coronary artery disease (CAD), chronic heart failure (CHF), hypertensive heart disease (HHD), arrhythmia, cardiomegaly, left ventricular hypertrophy (LVH), mitral regurgitation (MR), and myocardial injury (MI)]. Clinical outcomes include in-hospital mortality, intensive care unit admission, ventilator use, earlier death, and prolonged hospital stay. Mann\u2013Whitney test was used for analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The most common CVD was hypertension (48.1%), followed by MI (10.6%), CAD (9.2%), CHF (6.8%), HHD (3.1%), arrhythmia (1.7%), and others (0.7%). The in-hospital mortality rate was 24%, and patients were hospitalized for a median of 12\u2009days. MI was the only CVD that increased in-hospital mortality (RR 2.105). It was also significantly increased in patients with diabetes mellitus (RR 1.475) and chronic kidney disease (RR 2.079). Meanwhile, prolonged hospital stay was associated with any CVD (RR 1.553), hypertension (RR 1.511), MI (RR 1.969), CHF (RR 1.595), diabetes mellitus (RR 1.359), and cerebrovascular disease (RR 2.203).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>COVID-19 pneumonia in patients with CVD, specifically MI and hypertension, worsens the COVID-19 clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1190148","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:21:00Z","timestamp":1688048460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between cardiovascular diseases and COVID-19 pneumonia outcome in Indonesia: a multi-center cohort study"],"prefix":"10.3389","volume":"10","author":[{"given":"Erlina","family":"Burhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Aliyah Said Utriyani","family":"Adilah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cut Yulia Indah","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efriadi","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puji","family":"Astuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmina","family":"Hanifah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvan","family":"Wiyarta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana Maya","family":"Suryana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"volume-title":"Who COVID-19 dashboard: World Health Organization","year":"2020","key":"ref1"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14787210.2020.1822737","article-title":"COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up","volume":"19","author":"Tajbakhsh","year":"2021","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"117723","DOI":"10.1016\/j.lfs.2020.117723","article-title":"Myocardial injury and COVID-19: possible mechanisms","volume":"253","author":"Babapoor-Farrokhran","year":"2020","journal-title":"Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"100650","DOI":"10.1016\/j.hlpt.2022.100650","article-title":"Overcoming the COVID-19 pandemic in Indonesia: a science, technology, and innovation (STI) policy perspective","volume":"11","author":"Putera","year":"2022","journal-title":"Health Policy Technol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.amjcard.2020.11.009","article-title":"Meta-analysis comparing outcomes in patients with and without cardiac injury and coronavirus disease 2019 (COVID 19)","volume":"141","author":"Bansal","year":"2021","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.pcad.2020.04.008","article-title":"The impact of 2019 novel coronavirus on heart injury: a systematic review and meta-analysis","volume":"63","author":"Li","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pcad.2022.09.002","article-title":"Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States","volume":"74","author":"Vasudeva","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.mayocpiqo.2022.08.001","article-title":"Cardiovascular risks and outcome in COVID-19 positive patients with cardiovascular disease attending primary health Care Corporation in Qatar: a retrospective cohort study","volume":"6","author":"Azeez","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.39339.610000.BE","article-title":"The declaration of Helsinki","volume":"335","author":"Goodyear","year":"2007","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0243471","DOI":"10.1371\/journal.pone.0243471","article-title":"Correction: impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis","volume":"15","author":"Sabatino","year":"2020","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5334\/gh.814","article-title":"The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis","volume":"15","author":"Matsushita","year":"2020","journal-title":"Glob Heart"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3760\/cma.j.cn112148-20200228-00137","article-title":"Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients","volume":"48","author":"He","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3390\/jcm10102096","article-title":"Myocardial injury in COVID-19 patients: association with inflammation, coagulopathy and in-hospital prognosis","volume":"10","author":"Ar\u00e9valos","year":"2021","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5114\/amsad.2021.105255","article-title":"Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19","volume":"6","author":"Ramphul","year":"2021","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jinf.2020.05.056","article-title":"COVID-19 is more severe in patients with hypertension; ACEI\/ARB treatment does not influence clinical severity and outcome","volume":"81","author":"Hu","year":"2020","journal-title":"J Infect"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40292-022-00506-9","article-title":"Hypertension and COVID-19: current evidence and perspectives","volume":"29","author":"Gallo","year":"2022","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"108794","DOI":"10.1016\/j.diabres.2021.108794","article-title":"Heart failure outcomes and Covid-19","volume":"175","author":"Standl","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.lanwpc.2021.100108","article-title":"Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study","volume":"9","author":"Surendra","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10741-023-10303-8","article-title":"Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications","volume":"10","author":"Bezati","year":"2023","journal-title":"Heart Fail Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.jacc.2021.03.010","article-title":"Impact of pneumonia in heart failure patients","volume":"77","author":"Mancini","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.5935\/abc.20180037","article-title":"Infection in patients with decompensated heart failure: in-hospital mortality and outcome","volume":"110","author":"Cardoso","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e28122","DOI":"10.1002\/jmv.28122","article-title":"COVID-19 immunopathology: from acute diseases to chronic sequelae","volume":"95","author":"Arish","year":"2023","journal-title":"J Med Virol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"862571","DOI":"10.3389\/fcvm.2022.862571","article-title":"Clinical characterization and possible pathological mechanism of acute myocardial injury in COVID-19","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","article-title":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection","volume":"76","author":"Lala","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijcard.2021.06.028","article-title":"Prevalence and characteristics of myocardial injury during COVID-19 pandemic: a new role for high-sensitive troponin","volume":"338","author":"Maino","year":"2021","journal-title":"Int J Cardiol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1190148\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:21:04Z","timestamp":1688048464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1190148\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":29,"alternative-id":["10.3389\/fmed.2023.1190148"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1190148","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1190148"}}